Quantcast

Latest Morphinans Stories

2014-02-26 08:29:29

CORALVILLE, Iowa, Feb. 26, 2014 /PRNewswire/ -- KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain, announced today that President and CEO, Travis Mickle, Ph.D., will present at the Cowen and Company 34(th) Annual Health Care Conference at the Boston Marriott Copley Place in Boston, MA. Among the topics to be discussed, Dr. Mickle will provide an overview of KemPharm's development pipeline,...

2014-02-25 23:04:03

Pat Moore Foundation, an alcohol and drug treatment center located in Costa Mesa, California, responds to the recent rise in heroin usage and overdoses in America. Costa Mesa, California (PRWEB) February 25, 2014 Since the recent death of the famous actor Philip Seymour Hoffman, there’s been a significant spike in attention regarding heroin use. It is natural for people to want to make sense of such a tragedy, but unfortunately you can’t make sense of addiction. Heroin is a highly...

2014-02-25 14:13:52

RGS-9-2 protein affects not only addiction, but analgesic relief and tolerance Identifying the specific pathways that promote opioid addiction, pain relief, and tolerance are crucial for developing more effective and less dangerous analgesics, as well as developing new treatments for addiction. Now, new research from the Icahn School of Medicine at Mount Sinai reveals that opiate use alters the activity of a specific protein needed for the normal functioning of the brain's reward center....

2014-02-20 08:31:56

WAYNE, Pa., Feb. 20, 2014 /PRNewswire/ -- Egalet Corporation (Nasdaq: EGLT) ("Egalet") today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track status for both Egalet-001, an abuse-deterrent, extended-release, oral morphine formulation, and Egalet-002, an abuse-deterrent, extended-release, oral oxycodone formulation, both in development for the treatment of moderate to severe pain. http://photos.prnewswire.com/prnvar/20140219/NY67493LOGO FDA's Fast...

2014-02-19 08:31:29

WAYNE, Pa., Feb. 19, 2014 /PRNewswire/ -- Egalet Corporation (Nasdaq: EGLT) ("Egalet") today announced that Bob Radie, president and chief executive officer, is scheduled to present at the 34(th) Annual Cowen Health Care Conference in Boston on Tuesday, March 4, 2014 at 9:20 a.m. eastern standard time. Mr. Radie will provide an overview of the company's abuse-deterrent product candidates. The presentations that will be audio webcast live and available for replay will be available at...

2014-02-14 23:24:48

Passages Malibu CEO comments on sobering new research on cocaine and heroin users. Malibu, CA (PRWEB) February 14, 2014 The February 2014 issue of the Journal of Substance Abuse Treatment published an analysis of data on mortality risks of users of cocaine and heroin. That analysis showed users of those substances to be at 14 times higher risk of fatality, compared to the general population. The study was conducted in Spain and included a population of more than 8,800 participants...

2014-02-14 23:22:04

Treatment Center Finder is battling addiction on the front lines seven days a week. To handle this growing problem, the company's addiction hotline has expanded into 6 new states, bringing the total states covered by their services up to 12 states total now. (PRWEB) February 14, 2014 The problem of addiction has risen dramatically in recent years in the United States. In October of 2013 it was stated by the U.S. Department of Health and Human services that around 20.4 million people...

2014-02-13 23:22:35

Drug rehabilitation centers such as Narconon Arrowhead of Oklahoma experience a rise in the number of clients admitted for prescription drug use. Canadian, Oklahoma (PRWEB) February 13, 2014 According to the CDC (The Center for Disease Control and Prevention), deaths from prescription painkillers have reached epidemic levels in the past decade. The number of overdose deaths has become greater than deaths from heroin and cocaine combined. A big part of the problem is the nonmedical use of...

2014-02-13 08:30:13

RALEIGH, N.C., Feb. 13, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (Nasdaq: BDSI) announced that it has closed its previously announced registered direct offering with a select group of institutional investors under which such investors have purchased an aggregate of 7,500,000 shares of BDSI's common stock yielding gross proceeds of $60 million to BDSI. (Logo: http://photos.prnewswire.com/prnh/20110217/CL49801LOGO ) The lead investor in the financing was Federated...

2014-02-12 23:04:31

Citing effectiveness and unparalleled demand, Sunrise Nutraceuticals backs #1 rated opiate withdrawal relief supplement with 100% money-back guarantee Boca Raton, Fla. (PRWEB) February 12, 2014 Since its introduction last year, Elimidrol by Sunrise Nutraceuticals has already set itself apart from the competition by creating a truly effective opiate withdrawal supplement in an industry full of ineffective products. According to company representatives, both the Elimidrol Daytime and...


Word of the Day
lambent
  • Licking.
  • Hence Running along or over a surface, as if in the act of licking; flowing over or along; lapping or bathing; softly bright; gleaming.
This word comes the Latin 'lambere,' to lick.
Related